pharmaphorum

JANUARY 29, 2021

“Our work shows the benefits that patients and the NHS could get from rolling out a national screening programme as part of their plans to embed pharmacogenomics in clinical practice by 2025, and that this testing could be effectively delivered by community pharmacists. Estimating the potential impact of implementing pre?emptive

Clinical Pharmacology 98

Clinical Pharmacology Community Pharmacies 98

pharmaphorum

OCTOBER 18, 2021

8 It’s encouraging to see this as one of the goals in the EMA’s 2025 Regulatory Sciences Strategy. Integrated pathways for evaluation and regulatory approval could help reduce delays, in addition to more adaptive regulatory systems that will encourage innovation. Published 2021 Apr 9. Regulatory science strategy. Available from: [link].

Vaccines 143

Vaccines Clinical Pharmacology Pharmaceutical Companies Pharmaceutical Companies 143

pharmaphorum

NOVEMBER 1, 2022

billion by 2025, growing at a CAGR of 7.5%. Director, Clinical Pharmacology. Clinical Science Director. RNA therapeutics is a rapidly expanding industry with increasingly growing potential for immunotherapy, personalised medicines, and treatment of genetic, infectious, and chronic diseases. Chief Medical Officers.

Clinical Pharmacology 52

Clinical Pharmacology 52